Aurelius has acquired McKesson UK, the parent company of multiple healthcare businesses including Lloyds Pharmacy, AAH Pharmaceuticals, and John Bell & Croyden.

This acquisition is the fifth transaction in less than a year under Aurelius’ co-investment structure. McKesson UK includes four divisions: retail, digital, homecare, and wholesale. The firm holds a substantial market share across each vertical. Going forward, McKesson UK will transition away from its US-based parent company and will allow Aurelius to leverage its established market presence in the UK.

Aurelius was advised by Rothschild & Co, PwC and FRP, Interpath, Mayer Brown and DLA, Cardano, Kearney, and Mansfield.